Literature DB >> 9022007

X-SCID B cell responses to interleukin-4 and interleukin-13 are mediated by a receptor complex that includes the interleukin-4 receptor alpha chain (p140) but not the gamma c chain.

D J Matthews1, L Hibbert, K Friedrich, A Minty, R E Callard.   

Abstract

This study investigates the effect of interleukin (IL)-4 mutant proteins and a monoclonal antibody to the IL-4 receptor alpha chain on IL-4 and IL-13 response by B cells from X-linked severe combined immunodeficiency (X-SCID) patients in which the common gamma chain (gamma c chain) gene mutations have been fully characterized and no gamma c chain expression was detected. In this gamma c chain gene knockout model, it was confirmed that the gamma c chain is essential for B cell responses to IL-2 but not for IL-4 or IL-13. Dose-response curves for X-SCID and normal B cell responses to IL-4 were indistinguishable, showing that the loss of the gamma c chain did not diminish the sensitivity of B cells to IL-4. The mutant protein IL-4(Y124D) and an antibody to the IL-4R alpha chain both inhibited responses of X-SCID B cells to IL-4 and IL-13, showing that X-SCID B cell responses to these cytokines are mediated by a receptor complex that includes the IL-4R alpha chain but not the gamma c chain. Another mutant protein, IL-4(R88D), which has greatly reduced affinity for IL-4R alpha, was found to inhibit responses by normal B cells to IL-4 but not to IL-13. IL-4(R88D), did not, however, inhibit X-SCID B cell responses to IL-4. This result is consistent with IL-4(R88D) inhibition of responses mediated by receptor complexes that include the gamma c chain. We propose that X-SCID B cells responses to IL-4 are mediated by an IL-13 receptor complex comprised of the IL-4R alpha chain associated with the recently cloned IL-13R binding protein. This model has major implications for understanding normal B cell responses to IL-4.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9022007     DOI: 10.1002/eji.1830270118

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Resistin-like molecule-α regulates IL-13-induced chemokine production but not allergen-induced airway responses.

Authors:  Ariel Munitz; Eric T Cole; Danielle Karo-Atar; Fred D Finkelman; Marc E Rothenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-12       Impact factor: 6.914

2.  Alternative Splicing Rescues Loss of Common Gamma Chain Function and Results in IL-21R-like Deficiency.

Authors:  David Illig; Marta Navratil; Jadranka Kelečić; Raffaele Conca; Iva Hojsak; Oleg Jadrešin; Marijana Ćorić; Jurica Vuković; Meino Rohlfs; Sebastian Hollizeck; Jens Bohne; Christoph Klein; Daniel Kotlarz
Journal:  J Clin Immunol       Date:  2019-03-21       Impact factor: 8.317

3.  Case Report: Interleukin-2 Receptor Common Gamma Chain Defect Presented as a Hyper-IgE Syndrome.

Authors:  Brahim Belaid; Lydia Lamara Mahammed; Aida Mohand Oussaid; Melanie Migaud; Yasmine Khadri; Jean Laurent Casanova; Anne Puel; Nafissa Ben Halla; Reda Djidjik
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

4.  Polymorphic variants of interleukin-13 R130Q, interleukin-4 T589C, interleukin-4RA I50V, and interleukin-4RA Q576R in allergic rhinitis: A pilot study.

Authors:  Aravind Yadav; Gopala Krishnan Govindasamy; Rakesh Naidu
Journal:  Allergy Rhinol (Providence)       Date:  2012-05-18

5.  The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades.

Authors:  Yuan Xiao Zhu; Sally Benn; Zhi Hua Li; Ellen Wei; Esther Masih-Khan; Young Trieu; Meenakshi Bali; C Jane McGlade; Jaime O Claudio; A Keith Stewart
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.